Showing results (91-100 of 138) with videos related to
Sort By:
Pageof 14
Cancer|April 2, 2011
Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemiaMeir Wetzler, Chris Andrews, Laurie A Ford, et al.Leukemia Research|March 5, 2016
A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemiaElizabeth A Griffiths, William E Brady, Wei Tan, et al.Journal of Clinical Microbiology|April 9, 2004
Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipientImad Dibo, Satish K Pillai, Howard S Gold, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2014
Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemiaGeorge L Chen, Hong Liu, Yali Zhang, et al.Mycopathologia|March 17, 2005
Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristicsAasma Shaukat, Faris Bakri, Paul Young, et al.Asian Journal of Andrology|July 14, 2021
Apalutamide for patients with metastatic castrationsensitive prostate cancer in East Asia: a subgroup analysis of the TITAN trialByung Ha Chung, Jian Huang, Zhang-Qun Ye, et al.Leukemia Research|September 10, 2013
Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of ageCarlos E Vigil, Wei Tan, George Deeb, et al.Clinical Lymphoma, Myeloma & Leukemia|June 22, 2013
Subcutaneous omacetaxine mepesuccinate in patients with chronic-phase chronic myeloid leukemia previously treated with 2 or more tyrosine kinase inhibitors including imatinibJorge E Cortes, Franck E Nicolini, Meir Wetzler, et al.Molecular Cancer Therapeutics|October 7, 2010
Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia modelsDeepika Lal, Jennifer A Park, Kellie Demock, et al.Transplantation|December 16, 2004
Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletionTheresa Hahn, Arif Raza Alam, David Lawrence, et al.Pageof 14